These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26169576)

  • 1. Molecular neurobiology of major depressive disorder.
    Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():275-6. PubMed ID: 26169576
    [No Abstract]   [Full Text] [Related]  

  • 2. The neurobiology of treatment response to antidepressants and mood stabilizing medications.
    Young LT; Bakish D; Beaulieu S
    J Psychiatry Neurosci; 2002 Jul; 27(4):260-5. PubMed ID: 12174735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 inflammasome: a new target in major depressive disorder.
    Alcocer-Gómez E; Cordero MD
    CNS Neurosci Ther; 2014 Mar; 20(3):294-5. PubMed ID: 24479787
    [No Abstract]   [Full Text] [Related]  

  • 4. Glutamate hypothesis of depression and its consequences for antidepressant treatments.
    Musazzi L; Treccani G; Popoli M
    Expert Rev Neurother; 2012 Oct; 12(10):1169-72. PubMed ID: 23082730
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging drugs for major depressive disorder: an update.
    Rizvi SJ; Kennedy SH
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):285-94. PubMed ID: 22530790
    [No Abstract]   [Full Text] [Related]  

  • 6. Treat the brain and treat the periphery: toward a holistic approach to major depressive disorder.
    Zheng X; Zhang X; Wang G; Hao H
    Drug Discov Today; 2015 May; 20(5):562-8. PubMed ID: 25849660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
    Lai CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):240-1. PubMed ID: 19833160
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain, networks, depression, and more.
    Leistedt SJ; Linkowski P
    Eur Neuropsychopharmacol; 2013 Jan; 23(1):55-62. PubMed ID: 23154052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant response and polygenes.
    Purcell SM
    Biol Psychiatry; 2013 Apr; 73(7):600-1. PubMed ID: 23497743
    [No Abstract]   [Full Text] [Related]  

  • 10. Doctor's orders.
    Stafford N
    Ment Health Today; 2013; ():22. PubMed ID: 23638595
    [No Abstract]   [Full Text] [Related]  

  • 11. Forkhead box O transcription factors as possible mediators in the development of major depression.
    Wang H; Quirion R; Little PJ; Cheng Y; Feng ZP; Sun HS; Xu J; Zheng W
    Neuropharmacology; 2015 Dec; 99():527-37. PubMed ID: 26279492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan: the key to boosting brain serotonin synthesis in depressive illness.
    Badawy AA
    J Psychopharmacol; 2013 Oct; 27(10):878-93. PubMed ID: 23904410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):759-66. PubMed ID: 24684240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder.
    Weizman S; Gonda X; Dome P; Faludi G
    Neuropsychopharmacol Hung; 2012 Jun; 14(2):87-101. PubMed ID: 22710850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chipping away at major depressive disorder.
    Rucker JJ; McGuffin P
    Genome Biol; 2014 Jul; 15(7):421. PubMed ID: 25315250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Tencomnao T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):432; author reply 433. PubMed ID: 20036298
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis?
    Bambico FR; Belzung C
    Curr Top Behav Neurosci; 2013; 15():243-91. PubMed ID: 23271325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glutamatergic neurotransmission, depression and antidepressants].
    Ferrero A; Cereseto M
    Vertex; 2004; 15(56):91-8. PubMed ID: 15243652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on glutamate receptor antagonists as antidepressants.
    Chung C
    Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.